Joshua Bishop
Medical · Mullens, WVNPI 1760721039
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AstraZeneca at 27.9% of the total.
Across 180 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$817
- Novo Nordisk$458
- AbbVie$365
- GSK$217
- Lilly USA, LLC$181
- Merck$164
- plus $727 from 10 others
What the payments were for
- Food & beverage$2,929100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $817 |
| Novo Nordisk | 27 | $458 |
| AbbVie | 26 | $365 |
| GSK | 15 | $217 |
| Lilly USA, LLC | 11 | $181 |
| Merck | 9 | $164 |
| Amgen | 9 | $136 |
| Pfizer | 10 | $132 |
| Abbott | 8 | $131 |
| Redhill Biopharma Inc. | 10 | $114 |
| Idorsia Pharmaceuticals US Inc | 4 | $65 |
| Boehringer Ingelheim | 3 | $50 |
| Novartis | 2 | $38 |
| Genentech USA, Inc. | 2 | $29 |
| Amarin Pharma, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,929 in reported general payments places this provider in the 75th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $81,299 |
| FarxigaDapagliflozin Propanediol | 51 | $65,477 |
| JanuviaSitagliptin Phosphate | 58 | $51,627 |
| EliquisApixaban | 45 | $50,920 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $49,345 |
| JardianceEmpagliflozin | 30 | $37,166 |
| TrulicityDulaglutide | 15 | $34,135 |
| MounjaroTirzepatide | 20 | $29,920 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $29,310 |
| VascepaIcosapent Ethyl | 33 | $22,907 |
| XareltoRivaroxaban | 11 | $14,730 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $14,148 |
| EntrestoSacubitril/Valsartan | 12 | $11,078 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $9,353 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $9,319 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $817 | $94,78778 claims |
| Novo NordiskOzempic | $458 | $81,29957 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $181 | $64,05435 claims |
| MerckJanuvia, Janumet | $164 | $60,94769 claims |
| PfizerEliquis | $132 | $50,92045 claims |
| GSKTrelegy Ellipta | $217 | $49,34561 claims |
| Boehringer IngelheimJardiance | $50 | $37,16630 claims |
| NovartisEntresto | $38 | $11,07812 claims |
| AbbVieSynthroid | $365 | $2,34733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 233 medical providers in West Virginia.
Other medical in Mullens
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
- Mohammad YousafCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.